Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complete Cytologic Remission of V600E BRAF-Mutant Melanoma-Associated Leptomeningeal Carcinomatosis Upon Treatment With Dabrafenib.

× No keyword cloud information.

7 in total

Review 1. Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.

Authors: Keiran S M Smalley; Inna V Fedorenko; Rajappa S Kenchappa; Solmaz Sahebjam; Peter A Forsyth
Journal: Int J Cancer Date: 2016-04-30 Impact factor: 7.396

2. Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases.

Authors: Yingmei Li; Wenying Pan; Ian D Connolly; Sunil Reddy; Seema Nagpal; Stephen Quake; Melanie Hayden Gephart
Journal: J Neurooncol Date: 2016-03-09 Impact factor: 4.130

3. Implementation of cell-free tumor DNA sequencing from the cerebrospinal fluid to guide treatment in a patient with primary leptomeningeal melanoma: A case report.

Authors: Johannes C Melms; Ka-Wai Ho; Rohit Thummalapalli; Janice Tyler; Titus Josef Brinker; Veena Singh; Soma Sengupta; James Mier; Benjamin Izar
Journal: Mol Clin Oncol Date: 2018-05-09

Review 4. Leptomeningeal Metastases: New Opportunities in the Modern Era.

Authors: Jessica A Wilcox; Min Jun Li; Adrienne A Boire
Journal: Neurotherapeutics Date: 2022-07-05 Impact factor: 7.620

Review 5. Melanoma central nervous system metastases: current approaches, challenges, and opportunities.

Authors: Justine V Cohen; Hussain Tawbi; Kim A Margolin; Ravi Amravadi; Marcus Bosenberg; Priscilla K Brastianos; Veronica L Chiang; John de Groot; Isabella C Glitza; Meenhard Herlyn; Sheri L Holmen; Lucia B Jilaveanu; Andrew Lassman; Stergios Moschos; Michael A Postow; Reena Thomas; John A Tsiouris; Patrick Wen; Richard M White; Timothy Turnham; Michael A Davies; Harriet M Kluger
Journal: Pigment Cell Melanoma Res Date: 2016-10-22 Impact factor: 4.693

Review 6. Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy.

Authors: Katharine Hall Thomas; Robert A Ramirez
Journal: Ochsner J Date: 2017

Review 7. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.

Authors: Yolanda Piña; Sirisha Yadugiri; Debra N Yeboa; Sherise D Ferguson; Peter A Forsyth; Isabella C Glitza Oliva
Journal: Curr Oncol Rep Date: 2022-01-20 Impact factor: 5.075

7 in total